These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38989457)

  • 1. Biomineralization-inspired synthesis of autologous cancer vaccines for personalized metallo-immunotherapy.
    Li Q; Yan Y; Wang C; Dong Z; Hao Y; Chen M; Liu Z; Feng L
    iScience; 2024 Jul; 27(7):110189. PubMed ID: 38989457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A General Biomineralization Strategy to Synthesize Autologous Cancer Vaccines with cGAS-STING Activating Capacity for Postsurgical Immunotherapy.
    Li Q; Dong Z; Cao Z; Lei H; Wang C; Hao Y; Feng L; Liu Z
    ACS Nano; 2023 Jun; 17(11):10496-10510. PubMed ID: 37184402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid-Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer.
    Chen F; Li T; Zhang H; Saeed M; Liu X; Huang L; Wang X; Gao J; Hou B; Lai Y; Ding C; Xu Z; Xie Z; Luo M; Yu H
    Adv Mater; 2023 Mar; 35(10):e2209910. PubMed ID: 36576344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orchestrated Cytosolic Delivery of Antigen and Adjuvant by Manganese Ion-Coordinated Nanovaccine for Enhanced Cancer Immunotherapy.
    Gao ZL; Xu W; Zheng SJ; Duan QJ; Liu R; Du JZ
    Nano Lett; 2023 Mar; 23(5):1904-1913. PubMed ID: 36801829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential reinforcement of cGAS-STING pathway-involved immunotherapy by biomineralized bacterial outer membrane-sensitized EBRT and RNT.
    Shen M; Guo L; Zhang H; Zheng B; Liu X; Gu J; Yang T; Sun C; Yi X
    J Nanobiotechnology; 2024 Jun; 22(1):310. PubMed ID: 38831378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
    Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
    Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc-Organometallic Framework Vaccine Controlled-Release Zn
    Ding L; Liang M; Li Y; Zeng M; Liu M; Ma W; Chen F; Li C; Reis RL; Li FR; Wang Y
    Adv Sci (Weinh); 2023 Sep; 10(27):e2302967. PubMed ID: 37439462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A generally minimalist strategy of constructing biomineralized high-efficiency personalized nanovaccine combined with immune checkpoint blockade for cancer immunotherapy.
    Zhang S; Feng Y; Meng M; Li Z; Li H; Lin L; Xu C; Chen J; Hao K; Tang Z; Tian H; Chen X
    Biomaterials; 2022 Oct; 289():121794. PubMed ID: 36113330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal Fe/Mn Nanoadjuvant with T1/T2 MRI Self-Navigation and Gas Generation for Ideal Vaccines with Precise Tracking.
    Huang W; Shi S; Jiang Y; Tian Y; Wang Y; Jiang D; Xu L; Chen T
    ACS Nano; 2023 Aug; 17(16):15590-15604. PubMed ID: 37530430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer.
    Zhou L; Hou B; Wang D; Sun F; Song R; Shao Q; Wang H; Yu H; Li Y
    Nano Lett; 2020 Jun; 20(6):4393-4402. PubMed ID: 32459969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-signaling pathway activation by pH responsive manganese particles for enhanced vaccination.
    Lv X; Huang J; Min J; Wang H; Xu Y; Zhang Z; Zhou X; Wang J; Liu Z; Zhao H
    J Control Release; 2023 May; 357():109-119. PubMed ID: 36738971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lanthanide-Nucleotide Coordination Nanoparticles for STING Activation.
    Luo Z; Liang X; He T; Qin X; Li X; Li Y; Li L; Loh XJ; Gong C; Liu X
    J Am Chem Soc; 2022 Sep; 144(36):16366-16377. PubMed ID: 36037283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP-Responsive Manganese-Based Bacterial Materials Synergistically Activate the cGAS-STING Pathway for Tumor Immunotherapy.
    Yang H; Yang S; Guo Q; Sheng J; Mao Z
    Adv Mater; 2024 Jun; 36(23):e2310189. PubMed ID: 38414097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy.
    Jiang X; Wang J; Zheng X; Liu Z; Zhang X; Li Y; Wilhelm J; Cao J; Huang G; Zhang J; Sumer B; Lea J; Lu Z; Gao J; Luo M
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35623658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional hybrid exosomes enhanced cancer chemo-immunotherapy by activating the STING pathway.
    Cheng L; Zhang P; Liu Y; Liu Z; Tang J; Xu L; Liu J
    Biomaterials; 2023 Oct; 301():122259. PubMed ID: 37531777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manganese Coordination Micelles That Activate Stimulator of Interferon Genes and Capture In Situ Tumor Antigens for Cancer Metalloimmunotherapy.
    Li J; Ren H; Qiu Q; Yang X; Zhang J; Zhang C; Sun B; Lovell JF; Zhang Y
    ACS Nano; 2022 Oct; 16(10):16909-16923. PubMed ID: 36200692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cell-penetrating peptide-assisted nanovaccine promotes antigen cross-presentation and anti-tumor immune response.
    Liu X; Liu J; Liu D; Han Y; Xu H; Liu L; Leng X; Kong D
    Biomater Sci; 2019 Dec; 7(12):5516-5527. PubMed ID: 31670734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsive manganese-based nanoplatform amplifying cGAS-STING activation for immunotherapy.
    He Q; Zheng R; Ma J; Zhao L; Shi Y; Qiu J
    Biomater Res; 2023 Apr; 27(1):29. PubMed ID: 37061706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
    Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus-Based Vaccine Expressing a Modified Tumor Antigen Induces Potent Tumor-Specific CD8(+) T-cell Response and Protects Mice from Melanoma.
    Qiu Z; Huang H; Grenier JM; Perez OA; Smilowitz HM; Adler B; Khanna KM
    Cancer Immunol Res; 2015 May; 3(5):536-46. PubMed ID: 25633711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.